SignalCorporate

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Regulatory non-compliance notice threatens NYSE American listing status.

What changed

Regulatory non-compliance notice threatens NYSE American listing status.

Why it matters

Regulatory non-compliance notice threatens NYSE American listing status. — impact context not separately stored; see What changed.

Sources